Placental Growth Factor as Short-Term Predicting Biomarker in Acute Coronary Syndrome Patients with Non-ST Elevation Myocardial Infarction

Southern Medical Journal

Volumn 103, Issue 10, 2010, Pages 982-987

  Marković, Mirjana ^a   Ignjatović, Svetlana ^b   Dajak, Marijana ^b   Majkić Singh, Nada ^b  

^a University School of Pharmacy   (Serbia)

^b NONE

Author keywords

30 day outcome; Non ST elevation myocardial infarction; Placental growth factor

Indexed keywords

PLACENTAL GROWTH FACTOR; BIOLOGICAL MARKER; PLACENTA PROTEIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY CARE UNIT; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; THORAX PAIN; AGE; BLOOD; CONFIDENCE INTERVAL; ELECTROCARDIOGRAM; HEART INFARCTION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; TIME;

ACUTE CORONARY SYNDROME; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; ELECTROCARDIOGRAM PATTERN; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PREGNANCY PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 77958130426     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181eda4ef     Document Type: Article

References (37)

1. Tadros GM, McConnell TR, Wood GC, et al. Clinical predictors of 30-day cardiac events in patients with acute coronary syndrome at a community hospital. South Med J 2003;96:1113-1120.
2. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future [Review]. J Am Coll Cardiol 2006;48:1-11.
3. Mitchell AM, Brown MD, Menown IB, et al. Novel protein markers of acute coronary syndrome complications in low-risk outpatients: a systematic review of potential use in the emergency department. Clin Chem 2005;51:2005-2012.
4. Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations [Review]. Circulation 2006;113:2335-2362.
5. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-2538.
6. Apple FS, Wu AH, Mair J, et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome [Review]. Clin Chem 2005;51:810-824.
7. Iwama H, Uemura S, Naya N, et al. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. JAm Coll Cardiol 2006;47:1559-1567.
8. Apple FS, Smith SW, Pearce LA, et al. Assessment of the multiplebiomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2009;55:93-100.
9. Luttun A, Tjwa M, Moons L, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002;8:831-840.
10. Heeschen C, Dimmeler S, Fichtlscherer S, et al; CAPTURE Investigators. Prognostic value of placental growth factor in patients with acute chest pain. JAMA 2004;291:435-441.
11. Lenderink T, Heeschen C, Fichtischerer S, et al. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J Am Coll Cardiol 2006;47:307-311.
12. Apple FS, Pearce LA, Chung A, et al. Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2007;53:874-881.
13. Rashidi A, Ghanbarian A, Azizi F, et al. Is chronic kidney disease comparable to diabetes as a coronary artery disease risk factor? South Med J 2007;100:20-26.
14. Morrow DA, Cannon CP, Jesse RL; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007;53:552-574.
15. Martinez-Rumayor A, Januzzi JL Jr. Non-ST segment elevation acute coronary syndromes: a comprehensive review. South Med J 2006;99: 1109-1110.
16. Dajak M, Marković M, Ignjatović S, Majkić-Singh N. Evaluation of quantikine ELISA test for the measurement of placental growth factor. Jugoslov Med Biochem 2006;25:4-488.
17. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function - measured and estimated glomerular filtration rate. New Eng J Med2006; 354:2473-2483.
18. Thomas L, Huber AR. Renal function - estimation of glomerular filtration rate. Clin Chem Lab Med 2006;44:1295-1302.
19. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355-1374.
20. Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 2007;27:15-26.
21. Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes: part I: introduction and cytokines. Circulation 2006;113:e72-e75.
22. Persico MG, Vincenti V, DiPalma. Structure, expression and receptorbinding properties of placenta growth factor (PlGF). Curr Top Microbiol Immunol 1999;237:31-40.
23. Athanassiades A, Lala PK. Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta 1998;19:465-473.
24. Cao Y, Ji WR, Qi P, et al. Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem Biophys Res Commun 1997;235:493-498.
25. Hauser S, Weich HA. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 1993;9:259-268.
26. Failla CM, Odorisio T, Cianfarani F, et al. Placenta growth factor is induced in human keratinocytes during wound healing. J Invest Dermatol 2000;115:388-395.
27. Tordjman R, Delaire S, Plouët J, et al. Erythroblasts are a source of angiogenic factors. Blood 2001;97:1968-1974.
28. Bottomley MJ, Webb NJ, Watson CJ, et al. Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clin Exp Immunol 2000;119:182-188.
29. Autiero M, Luttun A, Tjwa M, et al. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 2003;1:1356-1370.
30. Keshet E. Preventing pathological regression of blood vessels. J Clin Invest 2003;112:27-29.
31. Wu AH. Markers for early detection of cardiac diseases. Scand J Clin Lab Invest Suppl 2005;240:112-121.
32. Cassidy A, Chiuve SE, Manson JE, et al. Potential role for plasma placental growth factor in predicting coronary heart disease risk in women. Arterioscler Thromb Vasc Biol 2009;29:134-139.
33. Hennekens CH. Risk factors for coronary heart disease in women. Cardiol Clin 1998;16:1-8.
34. Milner KA, Funk M, Arnold A, et al. Typical symptoms are predictive of acute coronary syndromes in women. Am Heart J 2002;143:283-288.
35. Canto JG, Goldberg RJ, Hand MM, et al. Symptom presentation of women with acute coronary syndromes: myth vs reality. Arch Intern Med 2007;167:2405-2413.
36. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
37. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-S266.